Medplus Health
Pharmaceutical Retailers · MEDPLUS
Mid CapHealthcareHigh Growth
Murali Sivaraman
Chairman, Managing Director and CEO · Pragmatic
Company DNA
Performance-Driven
About
Medplus Health is a Mid Cap company in the Healthcare sector, listed on NSE as MEDPLUS. With a market cap of ₹10K Cr and revenue of ₹6K Cr, it is currently in the High Growth phase. Known for its Performance-Driven culture and Disruptor approach to innovation, the company operates at a Startup-Speed pace. Rapid retail scale-up model requires intense operational efficiency and sales-focused performance metrics. Its strategic mandate: Rapid footprint expansion in the fragmented pharmacy retail space necessitates a scalable, technology-forward growth strategy.
FAQ
What kind of company is Medplus Health?
Medplus Health is a Mid Cap Healthcare company (MEDPLUS) in the High Growth phase with a market cap of ₹10K Cr. It is classified as Performance-Driven in culture.
What is Medplus Health's culture and work environment like?
Medplus Health has a Performance-Driven culture with Disruptor innovation DNA and a Startup-Speed pace of execution. Employee brand: Demanding Machine. Customer relationship style: Mass-Consumer. Rapid retail scale-up model requires intense operational efficiency and sales-focused performance metrics.
Who leads Medplus Health?
Medplus Health is led by Murali Sivaraman (Chairman, Managing Director and CEO), a Pragmatic leader with 40 years of experience.
What are Medplus Health's financials?
Medplus Health reported revenue of ₹6K Cr in FY25 with a 5-year revenue CAGR of 17.5%. Operating margin: 3.9%. Market cap: ₹10K Cr.
Culture & Strategy
CulturePerformance-Driven
InnovationDisruptor
PaceStartup-Speed
PurposeProfit-Pure
CustomerMass-Consumer
EmployeeDemanding Machine
BrandValue-Champion
LifecycleHigh Growth
Rapid retail scale-up model requires intense operational efficiency and sales-focused performance metrics.
Mandate
Rapid footprint expansion in the fragmented pharmacy retail space necessitates a scalable, technology-forward growth strategy.
Rapid footprint expansion in the fragmented pharmacy retail space necessitates a scalable, technology-forward growth strategy.
Financials
Revenue FY25₹6K Cr
PAT FY25₹150 Cr
Rev CAGR 5Y17.5%
OPM3.9%
NPM2.5%
ROE8.6%
ROCE8.6%
P/E49.3
Fwd P/E41.5
P/B5.5
D/E64.7
Mkt Cap₹10K Cr
Promoter41.7%
Institutional36.6%
Similar Culture
Could You Lead Medplus Health?
Take the Genome Benchmark →